Course of severe coronavirus (COVID-19) in a patient at risk

Abstract

The article is devoted to the peculiarities of the clinical course of severe coronavirus infection in a 59-year-old woman at risk for comorbidities. Data on the pathogenesis of the severe form of COVID-19 are presented. Prognostic laboratory signs of an unfavorable outcome of coronavirus infection in people at risk are considered. The patient management tactics are described in accordance with the protocol for the treatment of new coronavirus infection. The assessment of patient management at the outpatient stage is given.

A new coronavirus infection in at-risk patients can quickly lead to a worsening of the condition, which is manifested by severe lung damage not only according to computed tomography data, but also by the clinical symptom of ARDS. The severity of the condition in this category of patients is due to severe viral aggression, the development of a cytokine storm. The use of the recommended protocol for the treatment of new coronavirus infection in patients at risk does not always give the expected positive result.

Keywords

COVID-19 / severe form / prognostic laboratory signs / treatment protocol / negative experience

References

[1] Пшеничная Н.Ю., Веселова Е.И., Семенова Д.А., и др. COVID-19 — новая глобальная угроза человечеству // Эпидемиология и инфекционные болезни. Актуальные вопросы. – 2020. – № 1. – С. 6–13. [Pshenichnaya NYu, Veselova EI, Semenova DA, et al. COVID-19 is a new global threat to humanity. Epidemiology and infectious diseases. Current items. 2020;(1):6-13. (In Russ.)]. https://doi.org/10.18565/epidem.2020.10.1.6-13.

[2] Zhao Y, Zhao Z, Wang Y, et al. Single-Cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-n-Cov. bioRxiv. 2020. https://doi.org/10.1101/2020.01.26.919985.

[3] Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Clin Investigation.| 2020;98(Issue 1):219-227. https://doi.org/10.1016/j.kint.2020.04.003.

[4] Цинзерлинг В.А., Вашукова М.А., Васильева М.В., и др. Вопросы патоморфогенеза новой коронавирусной инфекции (COVID-19) // Журнал инфектологии. – 2020. – Т. 2. – № 2. – С. 5–11. [Zinserling VA, Vashukova MA, Vasilyeva MV, et al. Issues of pathology of a new coronavirus infection CoVID-19. Journal Infectology. 2020;12(2):5-11. (In Russ.)]. https://doi.org/10.22625/2072-6732-2020-12-2-5-11.

[5] Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID 19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-848. https://doi.org/10.1007/s00134-020-05991-x.

[6] Временные методические рекомендации. Профилактика, диагностика и лечение COVID-19. Версия 8 (03.09.2020). [Vremennyye metodicheskiye rekomendatsii. Profilaktika, diagnostika i lecheniye COVID-19. Versiya 8 (03.09.2020). (In Russ.)]. Доступно по: https://static-0.minzdrav.gov.ru/system/attachments/attaches/ 000/051/777/original/030902020_COVID-19_v8.pdf. Ссылка активна на 15.08.2020.

[7] Royal College of Physicians. National Early Warning Score (NEWS) 2 [Internet]. Available from: https://www.rcplondon.ac.uk/projects/outputs/national-early-warning-score-news-2.

[8] Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 5 (08.04.2020). [Vremennyye metodicheskiye rekomendatsii. Profilaktika, diagnostika i lecheniye novoy koronavirusnoy infektsii (COVID-19). Versiya 5 (08.04.2020). (In Russ.)]. Доступно по: https://www.garant.ru/products/ipo/prime/doc/73753942/. Ссылка активна на 15.08.2020.

RIGHTS & PERMISSIONS

Kuznetsov N.I., Vasiliev V.V., Romanova E.S., Startseva G.Y.